Back
Akero Therapeutics Vs. iBio Industry Stock Comparison
Buy
65
AKRO
Akero Therapeutics
Last Price:
32.75
Seasonality Move:
5.92%
Sell
36
IBIO
iBio
Last Price:
2.64
Seasonality Move:
-11.6%
Buy
65
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $31.20. The Score for AKRO is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
iBio (IBIO)
is a Sell
Is iBio a Buy, Sell or Hold?
- The current iBio [IBIO] share price is $2.45. The Score for IBIO is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- IBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $31.20
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 51.61 | Buy |
| Chaikin Money Flow: | 477302 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.34 - 33.04) | Buy |
| Bollinger Bands (100): | (24.94 - 30.5) | Buy |
IBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 49.63 | Sell |
| Chaikin Money Flow: | 139651 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.34 - 2.84) | Sell |
| Bollinger Bands (100): | (1.85 - 2.55) | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.45 | Buy |
| 20-day SMA: | 31.54 | Sell |
| 50-day SMA: | 29.74 | Buy |
| 200-day SMA: | 25.28 | Buy |
| 8-day EMA: | 30.86 | Buy |
| 20-day EMA: | 30.99 | Buy |
| 50-day EMA: | 29.83 | Buy |
| 200-day EMA: | 27.24 | Buy |
IBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.29 | Buy |
| 20-day SMA: | 2.52 | Sell |
| 50-day SMA: | 2.41 | Buy |
| 200-day SMA: | 2.02 | Buy |
| 8-day EMA: | 2.33 | Buy |
| 20-day EMA: | 2.44 | Buy |
| 50-day EMA: | 2.4 | Buy |
| 200-day EMA: | 3.89 | Sell |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
iBio Earnings Growth & IBIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $103.99 per share, and an increase next year of $5.67 per share.
Akero Therapeutics Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
iBio Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||